Default company panoramic image
7baba254 905b 456e 943b 6aabe40c0fa8


Atturos uses proteomics technology to help clinicians and patients make more informed treatment decisions for prostate cancer.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Pilates Dublin . ie, Dublin, Ireland
  • Currency EUR
  • Founded January 2013
  • Employees 2
  • Website

Company Summary

Atturos builds innovative biomarker-based diagnostic tests to support clinical decision making in prostate cancer. With its advanced protein biomarker discovery capability and MRM-based validation platform, Atturos has identified a panel of proteins predictive of extracapsular extension (ECE) in prostate cancer, which it is developing into a clinically validated test to ensure clinicians and patients make a more informed decision about treatment.


  • Default avatar
    Stephen Pennington - CSO


  • Default avatar
    Dolores Cahill - CEO